Ticker
RLMDCompany Name
RELMADA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Debt to Equity Ratio | Shareholders Equity | Total Liabilities |
---|---|---|---|
6/30/2025 | 0.32 | $ 15.95M | $ 5.17M |
3/31/2025 | 0.23 | $ 22.44M | $ 5.24M |
12/31/2024 | 0.29 | $ 35.52M | $ 10.3M |
9/30/2024 | 0.17 | $ 47.63M | $ 8.1M |
6/30/2024 | 0.16 | $ 61.49M | $ 9.54M |
3/31/2024 | 0.17 | $ 72.05M | $ 12.36M |
12/31/2023 | 0.14 | $ 85.36M | $ 12.19M |
9/30/2023 | 0.08 | $ 100.73M | $ 8.42M |
6/30/2023 | 0.1 | $ 111.34M | $ 10.7M |
3/31/2023 | 0.08 | $ 125.47M | $ 10.1M |
Liabilities / Equity
(=) D/E
D/E for RELMADA THERAPEUTICS INC is calculated as follows: Liabilities [ $ 3.39M ] / Equity [ $ 122.21M ]
(=) D/E [ 0.03 ]
Minimum
Sep 30, 2020
Maximum
Jun 30, 2025
Average
Median
filtered constituents | 3.3K |
---|---|
min | 0 |
max | 6.05 |
average | 1.39 |
median | 0.98 |
std | 1.31 |